openPR Logo
Press release

Recombinant Vaccines Market Industry Forecast till 2025

08-16-2018 12:52 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Recombinant vaccines are produced by using recombinant DNA technology or genetic engineering for the prevention of lethal diseases in human beings and animals. Recombinant vaccine is a biological preparation that provides active acquired immunity against a certain disease. Whereas individual being vaccinated produces antibodies against the protein antigen that protect a person from contracting the disease upon attack from the pathogenic microorganism. These vaccines functions on the immune response for diseases and to have preventive measures against diseases caused by various bacteria, and virus. These vaccines are much more advanced and effective as compare to conventional vaccines in the prevention of diseases such as malaria, typhoid, and human papillomavirus (HPV). Furthermore, Europe dominates the animal recombinant vaccines market as compared to other regions due to highly organized livestock and major demand for livestock products in Europe.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/455

According to World Health Organization (WHO), around 18 million fatalities were caused due to inaccessibility of treatment for their illness. According to World Health Organization Report 2017, in the U.S. it is possible to prevent 2 million - 3 million deaths every year by immunization and 1.5 million deaths are easily avoided by immunization. There were around 19.5 million infants did not get basic vaccine. There is constant development in technology which lead to the manufacture of more effective vaccines for disease and companies are working for the development of new vaccines for various disease such as zika virus, cancer and others.

The global recombinant vaccine market was valued at US$ 830.2 million in 2016 and is expected to witness a robust CAGR of 6.0% during the forecast period (2017 – 2025).

Increase in the incidence of zoonotic diseases and emerging technologies expected to support the growth of recombinant vaccines market

There is a constant increase in diseases caused by bacteria or virus such as swine flu, malaria, HPV and other diseases, which has raised the demand of vaccination and lead to the eradication of diseases such as polio, and tetanus in few countries. Whit the development in technology there is development in vaccines, which are more effective than conventional vaccines and does not lead to any side effect. These vaccines are easy to administer in the body orally, intramuscular or intradermal. In the U.S. there were around 212 million malaria cases and 429,000 deaths from malaria is reported in 2015. According to Centers for Disease Control and Prevention report 2017, in the U.S. there were around 49.9% of the children between the ages of 6 months to 17 years received an influenza vaccine.

Continuous investment in research & development for the development of new vaccines and increased awareness and pet adoption are expected to fuel the growth of recombinant vaccines

There are various companies working on the development of vaccine for various disease, which have affected human beings in short span of time such as Ebola, Zika, and H1N1 flu. The companies also working for the development of cancer vaccines different type of cancer includes lung cancer, blood cancer, skin cancer, bladder cancer, brain cancer, kidney cancer, prostate cancer, solid tumors cancer , breast cancer are the target area for recombinant vaccine development, which may expected to support the growth of recombinant vaccine market in the near future. In 2012, according to the World Cancer Research Fund International, globally around 1.7 million new cases of breast cancer are diagnosed. Breast cancers are being targeted in active NCI supported cancer prevention or treatment clinical trials using vaccines. The vaccine therapy with or without trastuzumab in treating patients with stage IV breast cancer is in phases II clinical trial. The folate receptor alpha peptide vaccine with GM-CSF in patient with triple negative breast cancer trial phase II.

Ask for customization @ https://www.coherentmarketinsights.com/insight/request-customization/455

According to National Cancer Institute, in the U.S. there were around 1,685,210 new cases of cancer was reported and 595,690 people died from cancer in 2016. According to American Society for the Prevention of Cruelty to Animals, in the U.S. there were around 3.2 million shelter animals are adopted each year (1.6 million dogs and 1.6 million cats) and adoption of pets are expected to increase, which in turn raise the demand for recombinant vaccines for animals in near future.

Some major key players in the recombinant vaccines market include Merck & Co. Inc., Novartis AG, Protein Science Corporation, GlaxoSmithKline Plc., Green Cross Corporation, Bayer AG, Sanofi S A, Pfizer Inc., and Bharat Biotech.

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Recombinant Vaccines Market Industry Forecast till 2025 here

News-ID: 1182750 • Views:

More Releases from Coherent Market Insights

Stargardt Disease Therapeutics Market to See Booming Growth 2024-2031 | Kubota Pharmaceutical Holdings Co., Ltd., Stargazer Pharmaceuticals Inc., Iveric Bio, Inc., Sanofi S.A., Alkeus Pharmaceuticals Inc.
Stargardt Disease Therapeutics Market to See Booming Growth 2024-2031 | Kubota P …
Latest report by Coherent Market Insights, titled 'Stargardt Disease Therapeutics Market - Size, Trends, Share, Growth, Dynamics, Competition, and Opportunity Forecast, 2024 - 2031,' offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report meticulously examines both macro and micro trends, offering insights into the dynamic factors influencing the market. It encompasses a detailed exploration of qualitative and quantitative aspects, delivering a precise
Plasminogen Activator Inhibitor Market Huge Growth in Future Scope 2024-2031 | Bayer AG, SteadyMed Ltd., GlaxoSmithKline plc, Pfizer Inc., Abcam plc
Plasminogen Activator Inhibitor Market Huge Growth in Future Scope 2024-2031 | B …
Latest report by Coherent Market Insights, titled 'Plasminogen Activator Inhibitor Market - Size, Trends, Share, Growth, Dynamics, Competition, and Opportunity Forecast, 2024 - 2031,' offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report meticulously examines both macro and micro trends, offering insights into the dynamic factors influencing the market. It encompasses a detailed exploration of qualitative and quantitative aspects, delivering a precise
Cordyceps Sinensis Extract Market Is Booming Worldwide 2024-2031 | Naturalin, Active Organics, Quyuan sunnycare Inc., Kangzhou, HERBSINO, SOST
Cordyceps Sinensis Extract Market Is Booming Worldwide 2024-2031 | Naturalin, Ac …
Latest report by Coherent Market Insights, titled 'Cordyceps Sinensis Extract Market - Size, Trends, Share, Growth, Dynamics, Competition, and Opportunity Forecast, 2024 - 2031,' offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report meticulously examines both macro and micro trends, offering insights into the dynamic factors influencing the market. It encompasses a detailed exploration of qualitative and quantitative aspects, delivering a precise
U.S. Transthyretin Amyloidosis Treatment Market See Incredible Growth 2024-2031 | Alnylam Pharmaceuticals, Inc., Pfizer, Inc., Prothena Corporation plc., GlaxoSmithKline plc.
U.S. Transthyretin Amyloidosis Treatment Market See Incredible Growth 2024-2031 …
Latest report by Coherent Market Insights, titled 'U.S. Transthyretin Amyloidosis Treatment Market - Size, Trends, Share, Growth, Dynamics, Competition, and Opportunity Forecast, 2024 - 2031,' offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report meticulously examines both macro and micro trends, offering insights into the dynamic factors influencing the market. It encompasses a detailed exploration of qualitative and quantitative aspects, delivering a

All 5 Releases


More Releases for Recombinant

Global Recombinant Vaccines Market Segmentation, Business Analysis and Forecast …
Global Recombinant Vaccines Market Analysis 2022-2028 Report provides strategists, marketers and senior management with the critical information they need to assess the global Recombinant Vaccines Market as it emerges from the Covid-19 shut down. The impact of Coronavirus (COVID-19) on global market has reinforced many trends already shaping the industry pre COVID-19, There is a long-term trend towards the repositioning of players as entertainment providers on multiple platforms. This study provides
Recombinant Protein Market Size, Share | Recombinant Protein Industry Future Gro …
Global Recombinant Protein Market Report provides a detailed industry overview along with the analysis of Cost Structure, Supply Chain, Development Techniques, Retailers Analysis, Financial Support, business Strategies, Marketing Channels. Global Recombinant Protein Market research report provides a point-by-pointIn-Depth analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations,
Human Recombinant Insulin Market Growth Analysis
"Industry analysis is a crucial step in the current competitive market space that helps identify the right target customers and accordingly provide tailored solutions for their business needs. Every aspect and unique challenges put up by the particular industry are carefully taken into consideration while formulating these solutions. It also takes into consideration various government reforms, competitive environment, customer behavior, existing and upcoming business models, and ever-evolving technological developments. Industry
United States Recombinant Vaccine Market Report
In this report, the United States Recombinant Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share
Recombinant Proteins Market 2022 | Recombinant Proteins Market: Global Industry …
Recombinant proteins play an imperative role in treating various diseases, such as hemophilia. Majority of the recombinant proteins used are human proteins, in order to compensate the functional proteins in vivo defects by increasing the protein function in a body. This Research Report Insights analyzes the expansion of global recombinant protein market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022. The next
Recombinant DNA Technology Market -
Recombinant DNA technology has allowed the transfer of desired characteristics which is useful to improve the existing systems by controlling expression of target genes. Recombinant DNA technology allows mass production of therapeutic proteins, which are characterized by high level of consistency and stability. The technology has multidisciplinary applications and potential to deal with important aspects of life, for instance, improving health, and enhancing food resources. The genetically modified plants have